Galibra Neuroscience, Inc.

Galibra Neuroscience is a biotechnology company founded in 2023 that develops gene therapy treatments for rare pediatric disorders caused by GABA-related gene variants, including developmental delay, autism, and epilepsy. The company uses gene replacement therapy and gene editing approaches to restore GABA balance in the brain.